147 related articles for article (PubMed ID: 19635169)
1. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).
Barraclough KA; Noble E; Leary D; Brown F; Hawley CM; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Sturtevant JM; Johnson DW
BMC Nephrol; 2009 Jul; 10():20. PubMed ID: 19635169
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
Barraclough KA; Brown F; Hawley CM; Leary D; Noble E; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Johnson DW
Nephrol Dial Transplant; 2012 Nov; 27(11):4146-53. PubMed ID: 22962411
[TBL] [Abstract][Full Text] [Related]
3. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.
Johnson DW; Hawley CM; Rosser B; Beller E; Thompson C; Fassett RG; Ferrari P; MacDonald S; Pedagogos E; Cass A
BMC Nephrol; 2008 Aug; 9():8. PubMed ID: 18671885
[TBL] [Abstract][Full Text] [Related]
4. Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.
Mudge DW; Tan KS; Miles R; Johnson DW; Campbell SB; Hawley CM; Isbel NM; Van Eps CL; Nicol DL
BMC Nephrol; 2009 Jun; 10():14. PubMed ID: 19500381
[TBL] [Abstract][Full Text] [Related]
5. Intravenous versus oral iron supplementation in peritoneal dialysis patients.
Johnson DW
Perit Dial Int; 2007 Jun; 27 Suppl 2():S255-60. PubMed ID: 17556315
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
McMahon LP; Kent AB; Kerr PG; Healy H; Irish AB; Cooper B; Kark A; Roger SD
Nephrol Dial Transplant; 2010 Mar; 25(3):920-6. PubMed ID: 19906658
[TBL] [Abstract][Full Text] [Related]
7. Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.
Canaud B; Mingardi G; Braun J; Aljama P; Kerr PG; Locatelli F; Villa G; Van Vlem B; McMahon AW; Kerloëguen C; Beyer U;
Nephrol Dial Transplant; 2008 Nov; 23(11):3654-61. PubMed ID: 18586762
[TBL] [Abstract][Full Text] [Related]
8. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.
Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
Nephrol Dial Transplant; 2001 Sep; 16(9):1879-84. PubMed ID: 11522873
[TBL] [Abstract][Full Text] [Related]
11. C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.
Macdougall IC; Walker R; Provenzano R; de Alvaro F; Locay HR; Nader PC; Locatelli F; Dougherty FC; Beyer U;
Clin J Am Soc Nephrol; 2008 Mar; 3(2):337-47. PubMed ID: 18287255
[TBL] [Abstract][Full Text] [Related]
12. Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease.
Grabe DW
Am J Health Syst Pharm; 2007 Jul; 64(13 Suppl 8):S8-14; quiz S23-5. PubMed ID: 17591995
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
Li WY; Chu TS; Huang JW; Wu MS; Wu KD
J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
[TBL] [Abstract][Full Text] [Related]
14. Oral versus intravenous iron supplementation in peritoneal dialysis patients.
Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
Perit Dial Int; 2001; 21 Suppl 3():S231-5. PubMed ID: 11887827
[TBL] [Abstract][Full Text] [Related]
15. A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients.
Mahajan S; Boulton H; Gokal R
J Nephrol; 2004; 17(5):687-92. PubMed ID: 15593036
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy.
Adhikary L; Acharya S
JNMA J Nepal Med Assoc; 2011; 51(183):133-6. PubMed ID: 22922860
[TBL] [Abstract][Full Text] [Related]
17. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
Stoves J; Inglis H; Newstead CG
Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
Wingard RL; Parker RA; Ismail N; Hakim RM
Am J Kidney Dis; 1995 Mar; 25(3):433-9. PubMed ID: 7872321
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial.
Zaim M; Piselli L; Fioravanti P; Kanony-Truc C
Eur J Nutr; 2012 Mar; 51(2):221-9. PubMed ID: 21643774
[TBL] [Abstract][Full Text] [Related]
20. Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.
Chen L; Jiang H; Gao W; Tu Y; Zhou Y; Li X; Zhu Z; Jiang Q; Zhan H; Yu J; Fu C; Gao Y
BMJ Open; 2016 Oct; 6(10):e012231. PubMed ID: 27855097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
